AGO2 Mediates Immunotherapy Failure via Suppressing Tumor IFN-Gamma Response-Dependent CD8⁺ T Cell Immunity

The authors showed that Argonaute 2 (AGO2), a key mediator in small RNA-guided gene regulation, inversely correlated with tumor responsiveness to interferon-gamma and the efficacy of immunotherapy.